Every SEC Form 3/4/5 on record for this filer (CIK 1517790) — 11 issuers, 18 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Director | 2026-06-15 → 2026-06-15 | 1 | — |
| TVTX | Travere Therapeutics, Inc. | Director | 2021-05-18 → 2026-05-21 | 6 | — |
| VIGL | Vigil Neuroscience, Inc. | Director | 2022-07-28 → 2025-08-05 | 10 | — |
| MNMD | Mind Medicine (MindMed) Inc. | Director | 2022-08-15 → 2025-06-16 | 5 | — |
| PLRX | PLIANT THERAPEUTICS, INC. | Director | 2020-06-02 → 2025-06-09 | 6 | — |
| AVTX | Avalo Therapeutics, Inc. | Director · lapsed | 2021-10-04 → 2021-11-12 | 2 | — |
| CERC | Cerecor Inc. | Director · lapsed | 2020-04-27 → 2021-07-02 | 9 | — |
| AGLE | Aeglea BioTherapeutics, Inc. | Director · lapsed | 2017-02-16 → 2020-06-10 | 5 | — |
| RTRX | Retrophin, Inc. | Director · lapsed | 2020-04-09 → 2020-04-09 | 2 | — |
| NVLN | NOVELION THERAPEUTICS INC. | Director · lapsed | 2017-10-04 → 2018-08-13 | 3 | — |
| RPTP | Raptor Pharmaceutical Corp | Director · lapsed | 2015-09-11 → 2016-10-26 | 3 | −$227,677 |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 11 issuers are covered and open a security page; the rest are on file here only.
